[Adults with congenital heart disease: treatment and medical problems]

A A Schmaltz1, U M M Bauer

  • 1ehemals Klinik für Kinderkardiologie, Universitätsklinikum Duisburg-Essen, Weg zur Platte 98, 45133, Essen, Deutschland, achim.schmaltz@web.de.

Herz
|August 15, 2013
PubMed

Insights

Medical advancements allow more children with congenital heart disease (ACHD) to survive, increasing the need for specialized care and guidelines. This summary covers key medical issues and treatment for ACHD patients.

Area of Science:

  • Cardiology
  • Pediatrics
  • Adult Congenital Heart Disease (ACHD)

Context:

  • Improved medical care leads to increased survival rates for children with congenital heart disease.
  • An estimated 203,000 to 301,000 ACHD patients in Germany require specialized care.
  • Scientific societies recognize the need for specialized ACHD care, establishing guidelines and certifications.

Purpose:

  • To summarize the medical challenges and care requirements for adult congenital heart disease (ACHD) patients.
  • To outline indications for treatment and postoperative care for common congenital heart defects.
  • To provide a resource for healthcare professionals managing ACHD.

Summary:

  • ACHD patients face complex medical issues including imaging, arrhythmias, heart failure, cyanosis, endocarditis prophylaxis, exercise, and pregnancy.
  • Guidelines and certifications are established to ensure specialized care for this growing patient population.
  • The summary details treatment indications and postoperative management for prevalent congenital heart defects.

Impact:

  • Facilitates standardized, high-quality care for a growing ACHD population.
  • Supports healthcare providers in managing complex ACHD cases.
  • Improves health outcomes and quality of life for individuals with congenital heart disease into adulthood.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...